KNSA
Kiniksa Pharmaceuticals Ltd
75.80$
+0.8%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | +400.3% | +471.2% | +22.7% | +56.6% | +60.1% | |
| – | +27.3% | +921.4% | +1,046.5% | +16.0% | +139.2% | +151.6% | +146.9% | +7.8% | +404.7% | |
| – | – | – | – | – | – | +570.0% | +8.3% | +69.5% | +2.2% | |
| – | +223.2% | +53.7% | +55.9% | -17.0% | -11.4% | -34.0% | +16.2% | +46.7% | -13.2% | |
| – | +37.8% | +138.4% | +62.1% | +29.6% | +89.6% | +14.0% | +22.4% | +30.6% | +25.4% | |
| – | +172.5% | +65.4% | +57.1% | -7.4% | +18.2% | +0.8% | +27.4% | +70.7% | -28.2% | |
| – | – | – | – | – | – | – | -357.8% | – | – | |
| – | – | – | – | -56.4% | -30.7% | -48.9% | – | – | – | |
| – | – | – | – | – | – | – | -251.0% | – | – | |
| – | -94.4% | -10,800.0% | – | – | -73.1% | -12,543.1% | – | – | +324.1% | |
| – | – | – | – | – | – | – | -92.3% | -406.7% | – | |
| – | – | – | – | – | – | – | -206.6% | – | – |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.